| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0969-2126(96)00153-0 |
| P698 | PubMed publication ID | 8994972 |
| P2093 | author name string | A Wonacott | |
| T Skarzynski | |||
| K Duncan | |||
| A Mistry | |||
| S E Hutchinson | |||
| V A Kelly | |||
| P2860 | cites work | MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures | Q26778412 |
| Structure and topological symmetry of the glyphosate target 5-enolpyruvylshikimate-3-phosphate synthase: a distinctive protein fold | Q27635452 | ||
| Vancomycin resistance: structure of D-alanine:D-alanine ligase at 2.3 A resolution | Q27730732 | ||
| Raster3D Version 2.0. A program for photorealistic molecular graphics | Q27860485 | ||
| Whole-genome random sequencing and assembly of Haemophilus influenzae Rd | Q27860765 | ||
| Free R value: a novel statistical quantity for assessing the accuracy of crystal structures | Q27860894 | ||
| Automated refinement of protein models | Q27860928 | ||
| Crystallographic R factor refinement by molecular dynamics | Q27860942 | ||
| The CCP4 suite: programs for protein crystallography | Q27861090 | ||
| Diffraction methods for biological macromolecules. Interactive computer graphics: FRODO | Q29618849 | ||
| Cloning and sequencing of Escherichia coli murZ and purification of its product, a UDP-N-acetylglucosamine enolpyruvyl transferase | Q33202551 | ||
| The mechanism of action of fosfomycin (phosphonomycin) | Q34214482 | ||
| The herbicide glyphosate is a potent inhibitor of 5-enolpyruvyl-shikimic acid-3-phosphate synthase | Q34286370 | ||
| Intracellular steps of bacterial cell wall peptidoglycan biosynthesis: enzymology, antibiotics, and antibiotic resistance | Q34541598 | ||
| Complete sequence and transcriptional analysis of the spo0F region of the Bacillus subtilis chromosome | Q36215269 | ||
| The UDP-N-acetylglucosamine 1-carboxyvinyl-transferase of Enterobacter cloacae. Molecular cloning, sequencing of the gene and overexpression of the enzyme | Q42610701 | ||
| Stable enzyme-phosphoenolpyruvate intermediate in the synthesis of uridine-5'-diphospho-N-acetyl-2-amino-2-deoxyglucose 3-0-enolpyruvyl ether | Q48004953 | ||
| The rRNA operons of Mycobacterium smegmatis and Mycobacterium tuberculosis: comparison of promoter elements and of neighbouring upstream genes | Q48065744 | ||
| Cloning and characterization of the Mycobacterium leprae putative ribosomal RNA promoter in Escherichia coli | Q48237489 | ||
| The reaction mechanism of the internal thioester in the human complement component C4. | Q50335847 | ||
| Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin. | Q54590227 | ||
| Structural studies of Escherichia coli UDP-N-acetylmuramate:L-alanine ligase. | Q54593807 | ||
| Analysis of Fluoromethyl Group Chirality Establishes a Common Stereochemical Course for the Enolpyruvyl Transfers Catalyzed by EPSP Synthase and UDP-GlcNAc Enolpyruvyl Transferase† | Q57567791 | ||
| Stereochemically restrained refinement of macromolecular structures | Q69806243 | ||
| Time-resolved solid-state REDOR NMR studies of UDP N-acetylglucosamine enolpyruvyl transferase | Q70841315 | ||
| An enzyme-substrate complex involved in bacterial cell wall biosynthesis | Q71726994 | ||
| Detection and characterization of a phospholactoyl-enzyme adduct in the reaction catalyzed by UDP-N-acetylglucosamine enolpyruvoyl transferase, MurZ | Q72160243 | ||
| Kinetics, stoichiometry, and identification of the reactive thiolate in the inactivation of UDP-GlcNAc enolpyruvoyl transferase by the antibiotic fosfomycin | Q72160246 | ||
| Phosphonomycin, a New Antibiotic Produced by Strains of Streptomyces | Q72475705 | ||
| Evidence that the reaction of the UDP-N-acetylglucosamine 1-carboxyvinyltransferase proceeds through the O-phosphothioketal of pyruvic acid bound to Cys115 of the enzyme | Q72709263 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 1465-74 | |
| P577 | publication date | 1996-12-15 | |
| P1433 | published in | Structure | Q15709970 |
| P1476 | title | Structure of UDP-N-acetylglucosamine enolpyruvyl transferase, an enzyme essential for the synthesis of bacterial peptidoglycan, complexed with substrate UDP-N-acetylglucosamine and the drug fosfomycin | |
| P478 | volume | 4 |
| Q42631237 | 'Intergenic' blr gene in Escherichia coli encodes a 41-residue membrane protein affecting intrinsic susceptibility to certain inhibitors of peptidoglycan synthesis |
| Q27642065 | A new view of the mechanisms of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) and 5-enolpyruvylshikimate-3-phosphate synthase (AroA) derived from X-ray structures of their tetrahedral reaction intermediate states |
| Q42647502 | A novel inhibitor that suspends the induced fit mechanism of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA). |
| Q37311884 | Biosynthesis of phosphonic and phosphinic acid natural products. |
| Q86910876 | Cell wall-affecting antibiotics modulate natural transformation in SigH-expressing Staphylococcus aureus |
| Q43871900 | Characterization and inhibition study of MurA enzyme by capillary electrophoresis |
| Q35747796 | Characterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Human and Pig in Taiwan |
| Q28539823 | Cloning, expression and characterization of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from Wolbachia endosymbiont of human lymphatic filarial parasite Brugia malayi |
| Q24633997 | Closing down on glyphosate inhibition--with a new structure for drug discovery |
| Q27622761 | Comparative X-ray analysis of the un-liganded fosfomycin-target murA |
| Q90224212 | Comparison of Antibiotic Resistance Mechanisms in Antibiotic-Producing and Pathogenic Bacteria |
| Q36702923 | Comparison of the essential cellular functions of the two murA genes of Bacillus anthracis |
| Q38420842 | Comprehensive structural and functional characterization of Mycobacterium tuberculosis UDP-NAG enolpyruvyl transferase (Mtb-MurA) and prediction of its accurate binding affinities with inhibitors |
| Q51773259 | Computed insight into a peptide inhibitor preventing the induced fit mechanism of MurA enzyme from Pseudomonas aeruginosa. |
| Q27621335 | Crystal structure of RNA 3'-terminal phosphate cyclase, a ubiquitous enzyme with unusual topology |
| Q33886827 | Crystal structure of UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase from Escherichia coli |
| Q37081699 | Cytoplasmic steps of peptidoglycan biosynthesis |
| Q36175676 | Differential antibacterial properties of the MurA inhibitors terreic acid and fosfomycin |
| Q88876823 | Elucidating the inhibition of peptidoglycan biosynthesis in Staphylococcus aureus by albocycline, a macrolactone isolated from Streptomyces maizeus |
| Q31896663 | Evaluating low level sequence identities. Are Aspergillus QUTA and AROM homologous? |
| Q90369671 | Evaluation of the efficacy of antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa in automated time-lapse microscopy and static time-kill experiments |
| Q37866109 | Evidence that the fosfomycin target Cys115 in UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) is essential for product release |
| Q45780905 | Fluorimetric analysis of the binding characteristics of 5-enolpyruvylshikimate-3-phosphate synthase with substrates in Dunaliella salina |
| Q28359895 | FosB, a cysteine-dependent fosfomycin resistance protein under the control of sigma(W), an extracytoplasmic-function sigma factor in Bacillus subtilis |
| Q36675246 | Fosfomycin |
| Q33732529 | Fosfomycin and Comparator Activity Against Select Enterobacteriaceae, Pseudomonas, and Enterococcus Urinary Tract Infection Isolates from the United States in 2012. |
| Q39071416 | Fosfomycin: Mechanism and Resistance |
| Q37957839 | Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens. |
| Q28363518 | Frequencies of amino acid strings in globular protein sequences indicate suppression of blocks of consecutive hydrophobic residues |
| Q27677546 | Functional Consequence of Covalent Reaction of Phosphoenolpyruvate with UDP-N-acetylglucosamine 1-Carboxyvinyltransferase (MurA) |
| Q33678531 | Fungal volatile compounds induce production of the secondary metabolite Sodorifen in Serratia plymuthica PRI-2C |
| Q27677278 | Heteroresistance to Fosfomycin Is Predominant in Streptococcus pneumoniae and Depends on the murA1 Gene |
| Q31016009 | Identification and characterization of new inhibitors of the Escherichia coli MurA enzyme |
| Q34473355 | Identification of a novel fosfomycin-resistant UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from a soil metagenome |
| Q48022320 | Identification of druggable targets for Acinetobacter baumannii via subtractive genomics and plausible inhibitors for MurA and MurB. |
| Q40257051 | In Vivo Pharmacokinetics and Pharmacodynamics of ZTI-01 (Fosfomycin for Injection) in the Neutropenic Murine Thigh Infection Model against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. |
| Q43190887 | Inhibitory mechanism of the Qβ lysis protein A2. |
| Q36518393 | Lipid Requirements for the Enzymatic Activity of MraY Translocases and in Vitro Reconstitution of the Lipid II Synthesis Pathway |
| Q43821664 | Mechanism-based inhibition of enzyme I of the Escherichia coli phosphotransferase system. Cysteine 502 is an essential residue |
| Q91657908 | Minimal fermentative metabolism fuels extracellular symbiont in a leaf beetle |
| Q36490822 | Molecular Basis for Resistance Against Phosphonate Antibiotics and Herbicides |
| Q26853135 | Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance |
| Q24627654 | Molecular basis of glyphosate resistance-different approaches through protein engineering |
| Q56784778 | Molecular modeling and bioinformatical analysis of the antibacterial target enzyme MurA from a drug design perspective |
| Q34145455 | MurAA is required for intrinsic cephalosporin resistance of Enterococcus faecalis |
| Q64898853 | Oral and intravenous fosfomycin in complicated urinary tract infections. |
| Q37810971 | Peptidoglycan biosynthesis machinery: a rich source of drug targets |
| Q40175191 | Pharmacodynamic Evaluation of Fosfomycin against Escherichia coli and Klebsiella spp. from Urinary Tract Infections and the Influence of pH on Fosfomycin Activities |
| Q35960788 | Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance |
| Q57169314 | Recent examples of α-ketoglutarate-dependent mononuclear non-haem iron enzymes in natural product biosyntheses |
| Q26859841 | Resistance to antibiotics targeted to the bacterial cell wall |
| Q24537302 | Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing |
| Q36718069 | Salt-bridge dynamics control substrate-induced conformational change in the membrane transporter GlpT. |
| Q39316874 | Simulation of spontaneous substrate binding revealing the binding pathway and mechanism and initial conformational response of GlpT. |
| Q27670812 | Structural and Functional Characterization of NikO, an Enolpyruvyl Transferase Essential in Nikkomycin Biosynthesis |
| Q36319020 | Structural and functional features of enzymes of Mycobacterium tuberculosis peptidoglycan biosynthesis as targets for drug development. |
| Q27622627 | Structural basis for the interaction of the fluorescence probe 8-anilino-1-naphthalene sulfonate (ANS) with the antibiotic target MurA |
| Q27678532 | Structure of MurA (UDP-N-acetylglucosamine enolpyruvyl transferase) fromVibrio fischeriin complex with substrate UDP-N-acetylglucosamine and the drug fosfomycin |
| Q33605661 | Structure-based discovery of antibacterial drugs |
| Q53603346 | Structure-based optimization of MurF inhibitors. |
| Q45325569 | Structures of Qβ virions, virus-like particles, and the Qβ-MurA complex reveal internal coat proteins and the mechanism of host lysis. |
| Q39257480 | Suppressor Mutations Linking gpsB with the First Committed Step of Peptidoglycan Biosynthesis in Listeria monocytogenes |
| Q51017942 | Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates. |
| Q27625346 | The 1.9 Å crystal structure ofEscherichia coliMurG, a membrane-associated glycosyltransferase involved in peptidoglycan biosynthesis |
| Q64938605 | The Combination of Fosfomycin plus Meropenem Is Synergistic for Pseudomonas aeruginosa PAO1 in a Hollow-Fiber Infection Model. |
| Q27660525 | The Fungal Product Terreic Acid Is a Covalent Inhibitor of the Bacterial Cell Wall Biosynthetic Enzyme UDP- N -Acetylglucosamine 1-Carboxyvinyltransferase (MurA), |
| Q34568935 | The bacterial cell wall as a source of antibacterial targets |
| Q26824482 | The structural biology of enzymes involved in natural product glycosylation |
| Q64984613 | Tobramycin-Linked Efflux Pump Inhibitor Conjugates Synergize Fluoroquinolones, Rifampicin and Fosfomycin against Multidrug-Resistant Pseudomonas aeruginosa. |
| Q33601835 | Two active forms of UDP-N-acetylglucosamine enolpyruvyl transferase in gram-positive bacteria |
| Q37913126 | UDP-N-acetylglucosamine enolpyruvyl transferase as a potential target for antibacterial chemotherapy: recent developments |
Search more.